Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Non-Current Deferred Tax Liability (2018 - 2025)

OptimizeRx's Non-Current Deferred Tax Liability history spans 8 years, with the latest figure at $4.5 million for Q3 2025.

  • For Q3 2025, Non-Current Deferred Tax Liability rose 65.6% year-over-year to $4.5 million; the TTM value through Sep 2025 reached $4.5 million, up 65.6%, while the annual FY2024 figure was $4.5 million, 3.55% up from the prior year.
  • Non-Current Deferred Tax Liability for Q3 2025 was $4.5 million at OptimizeRx, up from $3.5 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $4.5 million in Q4 2024 and bottomed at -$59000.0 in Q4 2022.
  • The 5-year median for Non-Current Deferred Tax Liability is $4.1 million (2023), against an average of $3.2 million.
  • The largest annual shift saw Non-Current Deferred Tax Liability tumbled 101.79% in 2021 before it skyrocketed 7450.85% in 2023.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at -$41000.0 in 2021, then tumbled by 43.9% to -$59000.0 in 2022, then surged by 7450.85% to $4.3 million in 2023, then grew by 3.55% to $4.5 million in 2024, then changed by 0.0% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Non-Current Deferred Tax Liability are $4.5 million (Q3 2025), $3.5 million (Q2 2025), and $3.8 million (Q1 2025).